a Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute, Salzburg, Austria; b Cancer Cluster Salzburg, Salzburg, Austria; c Department… Click to show full abstract
a Department of Internal Medicine III with Haematology, Medical Oncology, Haemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute, Salzburg, Austria; b Cancer Cluster Salzburg, Salzburg, Austria; c Department of Gynecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; d Klinische Abteilung für Onkologie, Universitätsklinik Graz, Graz, Austria; e Breast Center, Department of Oncology, Lausanne University Hospital CHUV, Lausanne, Switzerland; f Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; g Medical Oncology 2, Istituto Oncologico Veneto IOV-IRCCS, Padova, Italy Received: March 3, 2021 Accepted: March 10, 2021 Published online: March 26, 2021
               
Click one of the above tabs to view related content.